Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Receives $294.

20 hours ago · Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY - Get Free Report) has earned a consensus rating of "Moderate Buy" from the twenty-four brokerages that are covering the …

CouponFollow Extension

$294
OFF

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Receives $294.

1 week from now

20 hours ago · Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY - Get Free Report) has earned a consensus rating of "Moderate Buy" from the twenty-four brokerages that are covering the …

marketbeat.com

$0.87
OFF

Alnylam Pharmaceuticals (ALNY) Stock Price, News & Analysis

1 week from now

2 days ago · Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) posted its earnings results on Thursday, October, 31st. The biopharmaceutical company reported ($0.87) earnings per share …

marketbeat.com

$290
OFF

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Receives $290.

1 week from now

Oct 22, 2024 · Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY - Get Free Report) have been given a consensus rating of "Moderate Buy" by the twenty-four research firms that are …

marketbeat.com

$322.83
OFF

Alnylam Pharmaceuticals Stock: A Deep Dive Into Analyst ... - Nasdaq

1 week from now

4 days ago · In the assessment of 12-month price targets, analysts unveil insights for Alnylam Pharmaceuticals, presenting an average target of $322.83, a high estimate of $400.00, and a …

nasdaq.com

0%
OFF

Baillie Gifford & Co. Has $1.34 Billion Stock Holdings In Alnylam ...

1 week from now

5 days ago · Baillie Gifford & Co. trimmed its stake in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY - Free Report) by 19.0% in the third quarter, according to the company in its …

marketbeat.com

67%
OFF

ALNY Stock Price | Alnylam Pharmaceuticals Inc. Stock Quote (U.S ...

1 week from now

6 days ago · 1.67%. $2.72B. ALNY | Complete Alnylam Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

marketwatch.com

$234.88
OFF

Alnylam Pharmaceuticals Enters Oversold Territory (ALNY)

1 week from now

1 day ago · In trading on Friday, shares of Alnylam Pharmaceuticals Inc (Symbol: ALNY) entered into oversold territory, hitting an RSI reading of 28.5, after changing hands as low as $234.88 …

nasdaq.com

4%
OFF

Los Angeles Capital Management LLC Has $37.68 Million

1 week from now

6 days ago · Los Angeles Capital Management LLC boosted its stake in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY - Free Report) by 11,433.4% during the 3rd quarter, …

marketbeat.com

$294.50
OFF

Alnylam Pharmaceuticals (ALNY) Stock Forecast & Price Target

1 week from now

5 days ago · According to the 24 analysts' twelve-month price targets for Alnylam Pharmaceuticals, the average price target is $294.50. The highest price target for ALNY is …

marketbeat.com

FAQs about Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Receives $294. Coupon?

Is Alnylam Pharmaceuticals a good investment?

Alnylam Pharmaceuticals has received a consensus rating of Moderate Buy. Based on 15 buy ratings, 6 hold ratings, and no sell ratings, the company's average rating score is 2.71. According to analysts, Alnylam Pharmaceuticals has a forecasted upside of 43.2%, with a consensus price target of $234.76, which is higher than its current price of $163.96. ...

Who owns Alnylam Pharmaceuticals stock?

V Square Quantitative Management LLC now owns 334 shares of the biopharmaceutical company’s stock valued at $81,000 after purchasing an additional 60 shares during the last quarter. 92.97% of the stock is currently owned by institutional investors and hedge funds. Shares of Alnylam Pharmaceuticals stock opened at $235.56 on Friday. ...

How much did Alnylam Pharmaceuticals (ALNY) earn?

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) reported earnings per share of ($2.21) for the quarter, which was $0.49 more than the analysts' consensus estimates of ($1.72). ...

How do I receive news & ratings for Alnylam Pharmaceuticals?

Receive News & Ratings for Alnylam Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alnylam Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter. ...

Why did Alnylam Pharmaceuticals (ALNY) open more than 30% on Monday?

Alnylam Pharmaceuticals Inc (NASDAQ: ALNY) opened more than 30% up on Monday after reporting promising results from a late-stage trial of its heart drug. Shares of the biopharmaceutical company are n... ...

What does Alnylam Pharmaceuticals do?

(Get Free Report Alnylam Pharmaceuticals, Inc, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. ...